- Vestibulodynia: synergy between palmitoylethanolamide + Transpolydatin and transcutaneous electrical nerve stimulation
- Prevalence and predictors of vestibulodynia in reproductive-aged women with recurrent uncomplicated E. Coli-associated urinary tract infections
- Breast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy
- Medical treatments for sexual problems in women
- The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer
- Psychogenic causes of chronic pelvic pain, and its impact on psychological status
- Menopause and sexuality: key issues in premature menopause and beyond
- Opioids: how to improve compliance and adherence
- Sexual pain disorders
- The recurrent vulvovaginal candidiasis: proposal of a personalized therapeutic protocol
- Botulinum toxin treatment of pelvic floor disorders and genital pain in women
- Central nervous system abnormalities in vaginismus
- Dyspareunia: clinical approach in the perimenopause
- Therapeutic options for postmenopausal female sexual dysfunction
- The mastcell, director of chronic pelvic pain orchestra: implications for the gynaecologist
- Role of mastcells in chronic inflammation, depression and pain
- HPV infection in women: psychosexual impact of genital warts and intraepithelial lesions
- Depression and the menopause: why antidepressants are not enough?
- Testosterone substitution therapy and women's sexual health
- HPV infection in women: clinical consequences, psychosexual impact and the chances of prevention
- Mast cells and their role in sexual pain disorders
- Menopausal status, hormone replacement therapy use and risk of self-reported physician-diagnosed osteoarthritis in women attending menopause clinics in Italy
- Sexual function and sexual distress in women with interstitial cystitis: a case-control study
- Coexisting idiopathic cervical dystonia and primary vaginismus. A case report
Vestibulodynia: synergy between palmitoylethanolamide + Transpolydatin and transcutaneous electrical nerve stimulation
Murina F. Graziottin A. Felice R. Radici G. Tognocchi C.
Vestibulodynia: synergy between palmitoylethanolamide + Transpolydatin and transcutaneous electrical nerve stimulation
Journal of Lower Genital Tract Disease 2013 Apr; 17 (2): 111-6
The study aimed to assess the effect of palmitoylethanolamide + transpolydatin combination in patients with vestibulodynia undergoing transcutaneous electrical nerve stimulation (TENS) therapy and to confirm the effectiveness of TENS also in a domiciliary protocol...
Vestibulodynia: synergy between palmitoylethanolamide + Transpolydatin and transcutaneous electrical nerve stimulation
Journal of Lower Genital Tract Disease 2013 Apr; 17 (2): 111-6
The study aimed to assess the effect of palmitoylethanolamide + transpolydatin combination in patients with vestibulodynia undergoing transcutaneous electrical nerve stimulation (TENS) therapy and to confirm the effectiveness of TENS also in a domiciliary protocol...
Prevalence and predictors of vestibulodynia in reproductive-aged women with recurrent uncomplicated E. Coli-associated urinary tract infections
Salonia A. Graziottin A. Nappi R.E. Saccà A. Ghezzi M. Rocchini L. Ferrari M. Castiglione F. Rigatti P. Montorsi F.
Prevalence and predictors of vestibulodynia in reproductive-aged women with recurrent uncomplicated E. Coli-associated urinary tract infections
13th Congress of the European Society for Sexual Medicine (ESSM), Malaga, Spain, November 14-17, 2010
A high rate of women with E. Coli associated rUTIs also complain of provoked vestibulodynia. In this context, the higher the prevalence of rUTIs the greater the risk of vestibulodynia...
Breast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy
Bitzer J. Kenemans P. Mueck A.O. FSDeducation Group (including A. Graziottin)
Breast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy
Maturitas, 2008 Mar 20; 59 (3): 209-18
Testosterone supplementation can be considered as a treatment option for surgically postmenopausal women with a distressful low sexual desire disorder, while on oestrogen therapy with or without progestagens. The purpose of this study is to review the available clinical data on the impact of exogenous testosterone containing postmenopausal hormone therapy on breast cancer risk....
Medical treatments for sexual problems in women
Graziottin A. Serafini A.
Medical treatments for sexual problems in women
in: Mulhall J.P .(Ed.) Incrocci L. Goldstein I. Rosen R. (Ass. Eds), Cancer and Sexual Health, Humana Press, 2011, p. 627-641
Cancer is increasingly more of a chronic than a fatal disease. More attention should be focused on restoring a satisfying QOL, which includes physical intimacy, sensuality, and sexuality. Unfortunately, sexual problems are usually neglected in female cancer survivors, with a specific denial of their biological basis, with symptoms being attributed to the negative psychological effect of cancer diagnosis and treatment per se and their negative affective consequences such as depression and anxiety...
Medical treatments for sexual problems in women
in: Mulhall J.P .(Ed.) Incrocci L. Goldstein I. Rosen R. (Ass. Eds), Cancer and Sexual Health, Humana Press, 2011, p. 627-641
Cancer is increasingly more of a chronic than a fatal disease. More attention should be focused on restoring a satisfying QOL, which includes physical intimacy, sensuality, and sexuality. Unfortunately, sexual problems are usually neglected in female cancer survivors, with a specific denial of their biological basis, with symptoms being attributed to the negative psychological effect of cancer diagnosis and treatment per se and their negative affective consequences such as depression and anxiety...
The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer
Cardoso F. Loibl S. Pagani O. Graziottin A. Panizza P. Martincich L. Gentilini O. Peccatori F. Fourquet A. Delaloge S. Marotti L. Penault-Llorca F. Kotti-Kitromilidou AM. Rodger A. Harbeck N.
The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer
Eur J Cancer. 2012 Dec; 48 (18): 3355-77. doi: 10.1016/j.ejca.2012.10.004. Epub 2012 Oct 29
EUSOMA (The European Society of Breast Cancer Specialists) is committed to writing recommendations on different topics of breast cancer care and which can be easily adopted and used by health professionals dedicated to the care of patients with breast cancer in their daily practice...
The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer
Eur J Cancer. 2012 Dec; 48 (18): 3355-77. doi: 10.1016/j.ejca.2012.10.004. Epub 2012 Oct 29
EUSOMA (The European Society of Breast Cancer Specialists) is committed to writing recommendations on different topics of breast cancer care and which can be easily adopted and used by health professionals dedicated to the care of patients with breast cancer in their daily practice...
Psychogenic causes of chronic pelvic pain, and its impact on psychological status
Graziottin A.
Psychogenic causes of Chronic Pelvic Pain and impact of CPP on psychological status
in: Vercellini P. (Ed), Chronic pelvic pain, Wiley, 2011, p. 29-39
Psychogenic factors can be powerful contributors of CPP, as predisposing, precipitating or maintaining factors of chronic stress. One of the currently most credited pathophysiologic reading is through the corticotropin-releasing factor (CRF) signaling pathways.
The paper updates...
Psychogenic causes of Chronic Pelvic Pain and impact of CPP on psychological status
in: Vercellini P. (Ed), Chronic pelvic pain, Wiley, 2011, p. 29-39
Psychogenic factors can be powerful contributors of CPP, as predisposing, precipitating or maintaining factors of chronic stress. One of the currently most credited pathophysiologic reading is through the corticotropin-releasing factor (CRF) signaling pathways.
The paper updates...
Menopause and sexuality: key issues in premature menopause and beyond
Graziottin A.
Menopause and sexuality: key issues in premature menopause and beyond
in: Creatsas G. Mastorakos G. (Eds.), Women's health and disease, Annals of The New York Academy of Sciences, 2010 Sep; 1205: 254-61
The ageing process and menopause are two potent contributors of female sexual dysfunction. The earlier the menopause, the more severe and complex the impact on sexuality is. The younger the woman, the less she realizes the different key goals of her life cycle (falling in love, having a satisfying sexual life, forming a stable couple, getting married, having a family) and the more pervasive the consequences on her sexual identity, sexual function, and sexual relationship can be...
Menopause and sexuality: key issues in premature menopause and beyond
in: Creatsas G. Mastorakos G. (Eds.), Women's health and disease, Annals of The New York Academy of Sciences, 2010 Sep; 1205: 254-61
The ageing process and menopause are two potent contributors of female sexual dysfunction. The earlier the menopause, the more severe and complex the impact on sexuality is. The younger the woman, the less she realizes the different key goals of her life cycle (falling in love, having a satisfying sexual life, forming a stable couple, getting married, having a family) and the more pervasive the consequences on her sexual identity, sexual function, and sexual relationship can be...
Opioids: how to improve compliance and adherence
Graziottin A. Gardner-Nix J. Stumpf M. Berliner M.N
Opioids: how to improve compliance and adherence
Pain Practice 2011 Nov; 11 (6): 574-81
The treatment of chronic pain is a major worldwide public health issue. In 4 studies that used the International Association for the Study of Pain (IASP) definition for chronic pain, the prevalence of pain > 3 months duration ranged from 11.5% to 55.2%...
Opioids: how to improve compliance and adherence
Pain Practice 2011 Nov; 11 (6): 574-81
The treatment of chronic pain is a major worldwide public health issue. In 4 studies that used the International Association for the Study of Pain (IASP) definition for chronic pain, the prevalence of pain > 3 months duration ranged from 11.5% to 55.2%...
© 2008-2013 - Alessandra Graziottin Foundation
C.F./P.IVA: 060 829 20 965
Terms and conditions - Privacy policy - Credits